BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36507502)

  • 1. Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana.
    Tawe L; Ramatlho P; Ketlametswe R; Koobotse M; Robertson ES; Grover S; Ramogola-Masire D; Paganotti GM
    Front Med (Lausanne); 2022; 9():1020760. PubMed ID: 36507502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
    Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
    Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.
    Macleod IJ; O'Donnell B; Moyo S; Lockman S; Shapiro RL; Kayembe M; van Widenfelt E; Makhema J; Essex M; Wester C
    J Med Virol; 2011 Oct; 83(10):1689-95. PubMed ID: 21837784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G; You B; Mensah-Ado I; Bergeron C; Montcho C; Ramon R; Touré-Coulibaly K; Welffens-Ekra C; Dabis F; Orth G
    Int J Cancer; 1998 May; 76(4):480-6. PubMed ID: 9590121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Taku O; Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Businge CB; Williamson AL
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis.
    Bogale AL; Belay NB; Medhin G; Ali JH
    Virol J; 2020 Nov; 17(1):179. PubMed ID: 33198743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.
    Ermel A; Qadadri B; Tong Y; Orang'o O; Macharia B; Ramogola-Masire D; Zetola NM; Brown DR
    Infect Agent Cancer; 2016; 11():56. PubMed ID: 27843487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
    Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
    BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
    Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    Mboumba Bouassa RS; Nodjikouambaye ZA; Sadjoli D; Adawaye C; Péré H; Veyer D; Matta M; Robin L; Tonen-Wolyec S; Moussa AM; Koyalta D; Belec L
    PLoS One; 2019; 14(6):e0217486. PubMed ID: 31158254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana.
    Grover S; Zetola N; Ramogola-Masire D; Bvochora-Nsingo M; Schnader AF; Mick R; Gabaitiri L; Matlhagela K; Shen H; Chiyapo S; Balang D; Phaladze N; Nkomazana O; Friedman H; Jemmott J; Chilisa B; Robertson ES
    BMJ Open; 2019 Dec; 9(12):e031103. PubMed ID: 31892649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic HPV among HIV infected female population in West Bengal, India.
    Sarkar K; Pal R; Bal B; Saha B; Bhattacharya S; Sengupta S; Mazumdar PP; Chakraborti S
    BMC Infect Dis; 2011 Mar; 11():72. PubMed ID: 21418663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus, cancer and vaccination.
    Heard I
    Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.